Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05030272Completed
Randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: CO-verified 7-day point-prevalence abstinence at 24 weeks. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05030272.